Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Savient shares rise after FDA schedules March meeting to review gout drug
Savient shares rise after FDA schedules March meeting to review gout drug
Savient shares rise after FDA schedules March meeting to review gout drug
Submitted by
admin
on January 29, 2009 - 8:24am
Source:
Yahoo/AP
News Tags:
Savient
gout
FDA
Puricase
Headline:
Savient shares rise after FDA schedules March meeting to review gout drug
Do Not Allow Advertisers to Use My Personal information
